ecently, AI in health has become more popular as more startups created medical assistants powered by artificial intelligence to reduce the time spent
on taking notes and analyzing medical records.
So, the Zoom meeting company stated this Tuesday that they are in strong collaboration with Suki, the AI medical scribe provider, to create a platform where doctors and nurses can write notes about their patients. Currently, the video-conferencing platform and the AI in digital health are used for telehealth visits in the U.S., which is making Zoom maybe the most popular platform of its kind.
The founder and CEO of Suki AI, Punit Soni stated for the TechCrunch publication that the Zoom meeting platform has to choose from a lot of AI medical scribe startups before deciding to choose Suki AI as the provider. At the beginning of this month, Suki AI closed a $70 million Series D deal, that may have helped Zoom to decide which AI medical provider to choose for their collaboration.
Also, the founder and CEO of Zoom, Eric Yuan, made a statement earlier this month for Fortune where he said that the Zoom meeting platform is focusing on converting the platform into one that is more dedicated to creating artificial intelligence tools to integrate AI in health.
Subscribe to our newsletter
Besides Zoom and Suki AI, the One Medical platform which is owned by Amazon, has also integrated some AI tools to help hospital workers save time on administrative tasks. They chose to not collaborate with a startup in the industry, and they used Amazon’s Bedrock and AWS HealthScribe.
Many healthcare systems along with smaller offices of doctors believe that AI software can improve the overall spend time on the necessary documentation. And according to some investors, most of the companies in this field have seen some revenue back in a short time.
It’s important to keep in mind that currently, this market is a little bit crowded, but soon there is a high risk that those general-purpose foundational models will replace the AI medical scribe startups. However, some investors are still seeing some differences between these companies due to the fact that some platforms are focusing on smaller medical practices while others are looking to implement their tools in large medical systems.